Breast Cancer Kit - BRCAaccuTest™
Total solution for genetic breast cancer BRCA genetic test(CE-IVD)
Clinically validated next generation sequencing (NGS) panel and data analysis software for rapid and reliable detection of BRCA 1/2 mutations
BRCAaccuTestTM is a next generation sequencing (NGS)-based in vitro diagnostic (IVD) product which detects mutations in BRCA1 /BRCA2 genes. BRCAaccuTestTM consists of NGS panel for detecting variants and clinical data analysis software (S/W). Rapid and precise detection of various mutations in BRCA 1/2 with NGS can be accomplished and the user-oriented analysis software enables convenient generation of clinical report.
Features:
- Detection of mutations in the whole exon region coding for BRCA1 and BRCA2 gene proteins
- Experiment and decryption completed in 2 days
- Using DNA extracted from blood
- PCR amplicon-based library production
- Provide data QC, analysis and automated variant information by using optimized analysis software for BRCA1 and 2 panels
- Production and management from GMP and ISO 13485 certified organizations
- CE-IVD / KFDA Class III